VV116
Chinese Azvudone for COVID-19 China approves homegrown oral antiviral for treating COVID-19

The Chinese company producing Azvudone claimed that 40% of COVID-19 patients administered the drug for more than a week during the third phase of the clinical trial showed improvements when it came to symptoms